Search

Search Constraints

You searched for: Author/Creator Frezzini, Simona

Search Results

1. 2022-RA-956-ESGO Treatment patterns and outcomes after progression on poly-ADP ribose polymerase inhibitor maintenance therapy. (20th October 2022)

2. Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study. Issue 6 (30th April 2021)

3. Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO‐16A/MaNGO‐OV2A study. Issue 6 (June 2021)

4. Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial. Issue 2 (February 2021)

5. Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach. (December 2022)

6. Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial. Issue 10 (30th August 2021)

7. Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial. Issue 10 (30th October 2021)

8. Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study. Issue 7 (14th December 2019)